表紙
市場調查報告書

生物標記研究服務的全球市場:市場規模,佔有率,預測,市場機會分析 2018年∼2026年

Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

出版商 Coherent Market Insights 商品編碼 865087
出版日期 內容資訊 英文 178 Pages
商品交期: 2-3個工作天內
價格
Back to Top
生物標記研究服務的全球市場:市場規模,佔有率,預測,市場機會分析 2018年∼2026年 Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日期: 2019年05月11日內容資訊: 英文 178 Pages
簡介

精密醫療的開發相關舉措,及慢性疾病的盛行率的上升等促進全球生物標記研究服務市場成長。

本報告提供全球生物標記研究服務市場調查,市場概要,各服務類型、適應症、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 與調查目的假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場範圍

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各服務形式
    • 市場片段:各適應症
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 美國FDA認證生物標記
  • 法規方案
  • 美國FDA生物標記認證計劃
  • 主要的焦點
  • 聯合研究開發、合併、收購
  • PEST分析
  • 生物標記開發及實驗技術
  • 生物標記開發平台
  • 流行病學

第4章 全球生物標記研究服務市場:各服務形式

  • 簡介
  • 生物標記研究服務
  • 搭配診斷(CDx)研究服務

第5章 全球生物標記研究服務市場:各適應症

  • 簡介
  • 腫瘤
  • 心血管疾病
  • 感染疾病
  • 神經疾病
  • 免疫疾病
  • 其他

第6章 全球生物標記研究服務市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 非洲
  • 中東

第7章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Noble Life Sciences, Inc.
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc.

第8章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is included in the regulatory submission process for drug approval such as Investigational New Drug (IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are then accepted for use in that specific drug development program. Another process through which biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP), which qualifies a biomarker for a particular context of use (COU), independent of a drug approval submission. This pathway is intended for biomarkers that are used in multiple drug development programs. Qualified biomarkers have the potential to offer valuable information that may help during drug development.

Market Dynamics

Factors such as increasing initiatives for development of precision medicine, increasing prevalence of chronic diseases, and increasing demand for development of companion diagnostics, is supporting the growth of global biomarker research services market. For instance, in 2017, National Institutes of Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis, and in companion diagnostics is expected to boost global biomarker research services market growth. Organizations such as Covance, Inc., Charles River, and others are actively involved in providing biomarker research services.

Key features of the study:

  • This report provides in-depth analysis of global biomarker research services market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarker research services market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global biomarker research services market

Detailed Segmentation:

  • Global Biomarker Research Services Market, By Service Type:
    • Biomarker Research Services
    • CDx Research Services
  • Global Biomarker Research Services Market, By Disease Indication:
    • Oncology
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarker Research Services Market, By Region:
    • North America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country/Region:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Noble Life Sciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Qualified Biomarkers By U.S. FDA
  • Regulatory Scenario
  • U.S. FDA Biomarker Qualification Program
  • Key Highlights
  • Research and Development Collaboration, Mergers, and Acquisitions
  • PEST Analysis
  • Biomarker Development and Testing Technologies
  • Biomarker Development Pipeline
  • Epidemiology

4. Global Biomarker Research Services Market, By Service Type, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Biomarker Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Companion Diagnostics (CDx) Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

5. Global Biomarker Research Services Market, By Disease Indication, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Cardiovascular Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Neurological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Immunological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

6. Global Biomarker Research Services Market, By Regions, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2026
  • North America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Noble Life Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • REPROCELL Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Coriell Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioIVT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • ICON Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • SRI International
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Charles River Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nordic Bioscience A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Proteome Sciences Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top